Mini Review Immunological Consequences of Immunization With COVID-19 mRNA Vaccines: Preliminary Results

Background: BNT162b2 and mRNA-1273 are the two recently approved mRNA-based vaccines against COVID-19 which has shown excellent safety and efficacy. Preliminary data about specific and neutralizing antibodies is available covering the first 100 days after vaccination.Methods: We reviewed all the pub...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Andrea Lombardi, Giorgio Bozzi, Riccardo Ungaro, Simone Villa, Valeria Castelli, Davide Mangioni, Antonio Muscatello, Andrea Gori, Alessandra Bandera
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Frontiers Media S.A. 2021-03-01
Saila:	Frontiers in Immunology
Gaiak:	COVID-19 SARS-CoV-2 RNA vaccine CTL antibodies neutralization test
Sarrera elektronikoa:	https://www.frontiersin.org/articles/10.3389/fimmu.2021.657711/full
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!